Indian Pharma and Healthcare Sector Sees Significant Growth
According to Grant Thornton Bharat, India's pharma and healthcare sector recorded 72 deals worth USD 3.5 billion in Q3 2025, indicating a sharp rebound in investor confidence.
- 72 transactions were recorded in the third quarter of 2025.
- Three IPOs worth USD 428 million and a QIP worth USD 88 million were featured in the quarter.
- Private deals contributed USD 3 billion across 68 transactions, excluding public market moves.
Signalling a sharp rebound in investor confidence
Ruchika Sharma, Correspondent for the Business Section at Medical Dialogue, covers updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment.
Author's summary: India's pharma sector sees USD 3.5 billion deals.
More News
- Pashinyan Confident Armenians Will Support Peace Process in 2026 Parliamentary Election
- Uzbekistan pitches worldwide initiatives at UNESCO General Conference
- Colonizers Torch Vehicles in Burqa Amid Daily Attacks, Land Seizures
- Most Exciting Prospects for 2026: AL Central
- Thursday: Invasions, Violations, and Abductions Across West Bank
- An Obscure Military Program Helps Local Cops Buy Armored Cars and Spyware. It Might Balloon Under Trump.
- How Discrimination and Stress Impact the Mental Health of Young Sexual Minority Men
- THE LATIN AMERICA DIARIES ENTRY VIII: What makes you local? - Tracks Magazine
- Recruiting agencies warn of monopolization in Malaysia labour recruitment
- Nachiket Deshpande Honored for Advancing Global Cybersecurity Through Zero Trust Innovation